Share:
Peer-Reviewed Publication
Ther Adv Gastrointest Endosc2025;1826317745251359459.January 1, 2025Journal Article

Evaluating video capsule endoscopy in diabetes mellitus: transit times, preparation adequacy, and the influence of insulin and GLP-1 receptor agonist use.

Nimrod Akerman1, Naomi Fliss-Isakov2,3, Tamar Thurm1,2, Mati Shnell1,2, Yael Sofer1,4, Oren Shibolet1,2, Liat Deutsch5
1School of Medicine, Faculty of Medical & Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.
2Department of Gastroenterology and Liver Diseases, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
3Department of Health Promotions, School of Public Health, Faculty of Medical & Health Sciences, Tel-Aviv University, Tel Aviv, Israel.
4Department of Endocrinology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
5Head Clinical Nutrition and Capsule Endoscopy Service, Department of Gastroenterology and Liver Diseases, Tel-Aviv Sourasky Medical Center, 6 Weizmann St. Tel-Aviv, 6423906, Israel.

Abstract

BACKGROUND: Delayed gastrointestinal transit time (TT), frequently observed in diabetes mellitus (DM), may hinder bowel preparation quality and visualization in video capsule endoscopy (VCE). OBJECTIVES: The study aim was to compare VCE preparation adequacy and completion rates between patients with and without DM. DESIGN: Retrospective analysis of a prospectively maintained database, including…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.